Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 113.29% is 98% above its 5-year average of 57.20%, around the middle of its 5-year range (19.08%–242.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.54% below its 12-month average of 135.73%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 113.29%.
RETURN ON EQUITY (ROE)
113.29%
RETURN ON EQUITY (ROE) AVG TTM
135.73%
RETURN ON EQUITY (ROE) AVG 3Y
72.08%
RETURN ON EQUITY (ROE) AVG 5Y
57.20%
RETURN ON EQUITY (ROE) AVG 10Y
32.99%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.54%
CURRENT VS 3Y AVG
+57.17%
CURRENT VS 5Y AVG
+98.07%
CURRENT VS 10Y AVG
+243.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+770.75%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$17.32B
Return on Equity (ROE)
113.29%
TTM Avg
135.73%
3Y Avg
72.08%
5Y Avg
57.20%
Market Cap
$15.64B
Return on Equity (ROE)
3.29%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
Market Cap
$19.04B
Return on Equity (ROE)
6.39%
TTM Avg
6.40%
3Y Avg
5.73%
5Y Avg
4.16%
Market Cap
$15.60B
Return on Equity (ROE)
29.88%
TTM Avg
23.51%
3Y Avg
17.50%
5Y Avg
13.68%
Market Cap
$19.39B
Return on Equity (ROE)
-2.88%
TTM Avg
-13.64%
3Y Avg
-4.29%
5Y Avg
-4.38%
Market Cap
$14.30B
Return on Equity (ROE)
46.68%
TTM Avg
29.72%
3Y Avg
22.87%
5Y Avg
17.28%
Market Cap
$20.49B
Return on Equity (ROE)
11.17%
TTM Avg
10.12%
3Y Avg
7.00%
5Y Avg
7.00%
Market Cap
$21.24B
Return on Equity (ROE)
20.48%
TTM Avg
18.68%
3Y Avg
17.25%
5Y Avg
16.03%
Market Cap
$13.14B
Return on Equity (ROE)
-8.40%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.32B | 113.29% | 135.73% | 72.08% | 57.20% |
| Revvity, Inc. (RVTY)vs › | $15.64B | 3.29% | 3.59% | 3.35% | 7.68% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $19.04B | 6.39% | 6.40% | 5.73% | 4.16% |
| Solventum Corporation (SOLV)vs › | $15.60B | 29.88% | 23.51% | 17.50% | 13.68% |
| Viatris Inc. (VTRS)vs › | $19.39B | -2.88% | -13.64% | -4.29% | -4.38% |
| Exelixis, Inc. (EXEL)vs › | $14.30B | 46.68% | 29.72% | 22.87% | 17.28% |
| STERIS plc (STE)vs › | $20.49B | 11.17% | 10.12% | 7.00% | 7.00% |
| United Therapeutics Corporation (UTHR)vs › | $21.24B | 20.48% | 18.68% | 17.25% | 16.03% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.14B | -8.40% | -2.13% | 6.32% | 9.65% |
| Penumbra, Inc. (PEN)vs › | $12.54B | 10.49% | 6.83% | 5.29% | 3.21% |
ROE
113.3%
ROA
23.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 113.29% |
| 2026-03-31 | 76.95% |
| 2025-12-31 | 98.27% |
| 2025-09-30 | 147.46% |
| 2025-06-30 | 242.70% |
| 2025-03-31 | 70.15% |
| 2024-12-31 | 48.98% |
| 2024-09-30 | 41.49% |
| 2024-06-30 | 44.50% |
| 2024-03-31 | 46.54% |
| 2023-12-31 | 50.60% |
| 2023-09-30 | 58.01% |
| 2023-06-30 | 68.70% |
| 2023-03-31 | 73.99% |
| 2022-12-31 | 63.50% |
| 2022-09-30 | 64.80% |
| 2022-06-30 | 73.88% |
| 2022-03-31 | 33.03% |
| 2021-12-31 | 19.08% |
| 2021-09-30 | 20.34% |
| 2021-06-30 | 20.61% |
| 2021-03-31 | 18.60% |
| 2020-12-31 | 18.04% |
| 2020-09-30 | 15.71% |
| 2020-06-30 | 14.48% |
| 2020-03-31 | 15.35% |
| 2019-12-31 | 13.83% |
| 2019-09-30 | 13.50% |
| 2019-06-30 | 13.48% |
| 2019-03-31 | 12.52% |
| 2018-12-31 | 12.41% |
| 2018-09-30 | 10.99% |
| 2018-06-30 | 9.67% |
| 2018-03-31 | 8.85% |
| 2017-12-31 | 7.77% |
| 2017-09-30 | 5.05% |
| 2017-06-30 | 3.79% |
| 2017-03-31 | 2.97% |
| 2016-12-31 | 2.20% |
| 2016-09-30 | 0.80% |
| 2016-06-30 | -0.07% |
| 2016-03-31 | -1.24% |
| 2015-12-31 | -2.10% |
